Inici › Sobrepès › Florida › Miami
Assaigs clínics de Sobrepès a Miami, FL
23 estudis de Sobrepès busquen participants en centres de Miami i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
ReclutantFase 1
- Clinical Pharmacology of Miami, Miami
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutantFase 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
ReclutantFase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutantFase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
ReclutantFase 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutantFase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutantFase 3
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
ReclutantFase 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ReclutantFase 3
- Finlay Medical Research, Miami
- Suncoast Research Group LLC, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
ReclutantFase 3
- BioMed Research & Medical Center, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutantFase 2
- New Horizon Research Center, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ReclutantFase 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ReclutantFase 3Voluntaris sans benvinguts
- ACCOMPLISH-2 Research Site, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutantFase 2
- New Horizon Research Center, Miami
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
ReclutantFase 3
- Kailera Clinical Site, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutantFase 3
- Optimus U Corporation, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutantFase 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutantFase 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Assaigs de Sobrepès en altres ciutats
- San Antonio, TX34 estudis
- Houston, TX33 estudis
- Chicago, IL28 estudis
- Orlando, FL27 estudis
- Las Vegas, NV23 estudis
- Atlanta, GA20 estudis
- Dallas, TX20 estudis
- New York City, NY19 estudis
- Jacksonville, FL19 estudis
- Washington, DC19 estudis
- Austin, TX18 estudis
- Baltimore, MD17 estudis
Altres estudis a Miami
- Càncer de mama42 estudis
- Càncer (tots els tipus)36 estudis
- Càncer de pulmó de cèl·lules no petites31 estudis
- Càncer de pròstata27 estudis
- Obesitat27 estudis
- Leucèmia mieloide aguda24 estudis
- Càncer metastàtic24 estudis
- Càncer d'ovari23 estudis
- Mieloma múltiple21 estudis
- Colitis ulcerosa21 estudis
- Malaltia d'Alzheimer20 estudis
- Càncer de pulmó20 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.